alexa The International Federation of Pharmaceutical Manufacturers Associations (IFPMA)

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

The International Federation of Pharmaceutical Manufacturers Associations (IFPMA)

Formation of The International Federation of Pharmaceutical Manufacturers Associations (IFPMA) was in 1968.It is Global non-Profit NGO. IFPMA advocates policies that encourage discovery of and access to life-saving and life-enhancing medicines to grow the health of people everywhere and to promote and support principles of ethical conduct and practices. IFPMA shows research-based pharmaceutical companies and associations across the globe. The research-based pharmaceutical industry's 2 million members research, develop and provide medicines and vaccines that improve the life of patients global. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health neighborhood find solutions that improve global health. IFPMA hosts the Health Partnerships Directory, a continuously enlarging online database that allows users to view, in depth, health partnerships from across the world that involve the analysis-based biopharmaceutical industry. The IFPMA World Health Partnerships Directory is a table of partnerships between the research-based pharmaceutical industry and actors across all fields of global health serving together to meet present health needs and strengthen health systems in LMICs. With over 250 active case-studies presently charted, the IFPMA Directory is the largest resource of its kind, with programs that impact every country in the world. These health partnerships carry together governments, intergovernmental organizations, NGOs, private sector organizations, universities and foundations to gain the lives of people suffering from diseases like HIV/AIDS, malaria and tuberculosis, incommunicable diseases (NCDs) and neglected tropical diseases (NTDs), as well as cross-cutting threats like women and children’s health. In 2012 IFPMA released a strengthened code of ethics and professional standards. The International Pharmaceutical Congress Advisory Association (IPCAA) efforts in partnership with the managerial bodies European Federation of Pharmaceutical Industries and Associations and IFPMA.

Read More»